Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paolo Marinho de Andrade Zanotto is active.

Publication


Featured researches published by Paolo Marinho de Andrade Zanotto.


Nature | 2016

The Brazilian Zika virus strain causes birth defects in experimental models

Fernanda R. Cugola; Isabella Rodrigues Fernandes; Fabiele Baldino Russo; Beatriz C. Freitas; João Leonardo Rodrigues Mendonça Dias; Katia P. Guimarães; Cecília Benazzato; Nathalia Almeida; Graciela Conceição Pignatari; Sarah Romero; Carolina Manganeli Polonio; Isabela Cunha; Carla Longo de Freitas; Wesley Nogueira Brandão; Cristiano Rossato; David G. Andrade; Daniele de Paula Faria; Alexandre Teles Garcez; Carlos A. Buchpigel; Carla Torres Braconi; Érica A. Mendes; Amadou A. Sall; Paolo Marinho de Andrade Zanotto; Jean Pierre Schatzmann Peron; Alysson R. Muotri; Patricia Cristina Baleeiro Beltrão-Braga

Summary Zika virus (ZIKV) is an arbovirus belonging to the genus Flavivirus (Family Flaviviridae) and was first described in 1947 in Uganda following blood analyses of sentinel Rhesus monkeys1. Until the 20th century, the African and Asian lineages of the virus did not cause meaningful infections in humans. However, in 2007, vectored by Aedes aegypti mosquitoes, ZIKV caused the first noteworthy epidemic on the island of Yap in Micronesia2. Patients experienced fever, skin rash, arthralgia and conjunctivitis2. From 2013 to 2015, the Asian lineage of the virus caused further massive outbreaks in New Caledonia and French Polynesia. In 2013, ZIKV reached Brazil, later spreading to other countries in South and Central America3. In Brazil, the virus has been linked to congenital malformations, including microcephaly and other severe neurological diseases, such as Guillain-Barré syndrome4,5. Despite clinical evidence, direct experimental proof showing that the Brazilian ZIKV (ZIKVBR) strain causes birth defects remains missing6. Here we demonstrate that the ZIKVBR infects fetuses, causing intra-uterine growth restriction (IUGR), including signs of microcephaly in mice. Moreover, the virus infects human cortical progenitor cells, leading to an increase in cell death. Finally, we observed that the infection of human brain organoids resulted in a reduction of proliferative zones and disrupted cortical layers. These results indicate that ZIKVBR crosses the placenta and causes microcephaly by targeting cortical progenitor cells, inducing cell death by apoptosis and autophagy, impairing neurodevelopment. Our data reinforce the growing body of evidence linking the ZIKVBR outbreak to the alarming number of cases of congenital brain malformations. Our model can be used to determine the efficiency of therapeutic approaches to counteracting the harmful impact of ZIKVBR in human neurodevelopment.


Nature | 2016

Vaccine protection against Zika virus from Brazil

Rafael A. Larocca; Peter Abbink; Jean Pierre Schatzmann Peron; Paolo Marinho de Andrade Zanotto; M. Justin Iampietro; Alexander Badamchi-Zadeh; Michael Boyd; David Ng’ang’a; Marinela Kirilova; Ramya Nityanandam; Noe B. Mercado; Zhenfeng Li; Edward T. Moseley; Christine A. Bricault; Erica N. Borducchi; Patricia B. Giglio; David Jetton; George H. Neubauer; Joseph P. Nkolola; Lori F. Maxfield; Rafael De La Barrera; Richard G. Jarman; Kenneth H. Eckels; Nelson L. Michael; Stephen J. Thomas; Dan H. Barouch

Zika virus (ZIKV) is a flavivirus that is responsible for the current epidemic in Brazil and the Americas. ZIKV has been causally associated with fetal microcephaly, intrauterine growth restriction, and other birth defects in both humans and mice. The rapid development of a safe and effective ZIKV vaccine is a global health priority, but very little is currently known about ZIKV immunology and mechanisms of immune protection. Here we show that a single immunization with a plasmid DNA vaccine or a purified inactivated virus vaccine provides complete protection in susceptible mice against challenge with a strain of ZIKV involved in the outbreak in northeast Brazil. This ZIKV strain has recently been shown to cross the placenta and to induce fetal microcephaly and other congenital malformations in mice. We produced DNA vaccines expressing ZIKV pre-membrane and envelope (prM-Env), as well as a series of deletion mutants. The prM-Env DNA vaccine, but not the deletion mutants, afforded complete protection against ZIKV, as measured by absence of detectable viraemia following challenge, and protective efficacy correlated with Env-specific antibody titers. Adoptive transfer of purified IgG from vaccinated mice conferred passive protection, and depletion of CD4 and CD8 T lymphocytes in vaccinated mice did not abrogate this protection. These data demonstrate that protection against ZIKV challenge can be achieved by single-shot subunit and inactivated virus vaccines in mice and that Env-specific antibody titers represent key immunologic correlates of protection. Our findings suggest that the development of a ZIKV vaccine for humans is likely to be achievable.


Science | 2016

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

Peter Abbink; Rafael A. Larocca; Rafael De La Barrera; Christine A. Bricault; Edward T. Moseley; Michael Boyd; Marinela Kirilova; Zhenfeng Li; David Ng’ang’a; Ovini Nanayakkara; Ramya Nityanandam; Noe B. Mercado; Erica N. Borducchi; Arshi Agarwal; Amanda L. Brinkman; Crystal Cabral; Abishek Chandrashekar; Patricia B. Giglio; David Jetton; Jessica Jimenez; Benjamin C. Lee; Shanell Mojta; Katherine Molloy; Mayuri Shetty; George H. Neubauer; Kathryn E. Stephenson; Jean Pierre Schatzmann Peron; Paolo Marinho de Andrade Zanotto; Johnathan Misamore; Brad Finneyfrock

Zika virus (ZIKV) is responsible for a major ongoing epidemic in the Americas and has been causally associated with fetal microcephaly. The development of a safe and effective ZIKV vaccine is therefore an urgent global health priority. Here we demonstrate that three different vaccine platforms protect against ZIKV challenge in rhesus monkeys. A purified inactivated virus vaccine induced ZIKV-specific neutralizing antibodies and completely protected monkeys against ZIKV strains from both Brazil and Puerto Rico. Purified immunoglobulin from vaccinated monkeys also conferred passive protection in adoptive transfer studies. A plasmid DNA vaccine and a single-shot recombinant rhesus adenovirus serotype 52 vector vaccine, both expressing ZIKV premembrane and envelope, also elicited neutralizing antibodies and completely protected monkeys against ZIKV challenge. These data support the rapid clinical development of ZIKV vaccines for humans.


Journal of Virology | 2004

Sequence Analysis of the Genome of the Neodiprion sertifer Nucleopolyhedrovirus

Alejandra Garcia-Maruniak; James E. Maruniak; Paolo Marinho de Andrade Zanotto; Aissa E. Doumbouya; Jaw-Ching Liu; Thomas M. Merritt; Jennifer S. Lanoie

ABSTRACT The genome of the Neodiprion sertifer nucleopolyhedrovirus (NeseNPV), which infects the European pine sawfly, N. sertifer (Hymenoptera: Diprionidae), was sequenced and analyzed. The genome was 86,462 bp in size. The C+G content of 34% was lower than that of the majority of baculoviruses. A total of 90 methionine-initiated open reading frames (ORFs) with more than 50 amino acids and minimal overlapping were found. From those, 43 ORFs were homologous to other baculovirus ORFs, and 29 of these were from the 30 conserved core genes among all baculoviruses. A NeseNPV homolog to the ld130 gene, which is present in all other baculovirus genomes sequenced to date, could not be identified. Six NeseNPV ORFs were similar to non-baculovirus-related genes, one of which was a trypsin-like gene. Only one iap gene, containing a single BIR motif and a RING finger, was found in NeseNPV. Two NeseNPV ORFs (nese18 and nese19) were duplicates transcribed in opposite orientations from each other. NeseNPV did not have an AcMNPV ORF 2 homolog characterized as the baculovirus repeat ORF (bro). Six homologous regions (hrs) were located within the NeseNPV genome, each containing small palindromes embedded within direct repeats. A phylogenetic analysis was done to root the tree based upon the sequences of DNA polymerase genes of NeseNPV, 23 other baculoviruses, and other phyla. Baculovirus phylogeny was then constructed with 29 conserved genes from 24 baculovirus genomes. Culex nigripalpus nucleopolyhedrovirus (CuniNPV) was the most distantly related baculovirus, branching to the hymenopteran NeseNPV and the lepidopteran nucleopolyhedroviruses and granuloviruses.


PLOS Pathogens | 2009

Positive selection results in frequent reversible amino acid replacements in the G protein gene of human respiratory syncytial virus

Viviane Fongaro Botosso; Paolo Marinho de Andrade Zanotto; Mirthes Ueda; Eurico Arruda; Alfredo Elias Gilio; Sandra Elisabete Vieira; Klaus E. Stewien; Teresa Ct Peret; Leda Fátima Jamal; Maria Inês de Moura Campos Pardini; João Renato Rebello Pinho; Eduardo Massad; Osvaldo A. Sant'Anna; Edward C. Holmes; Edison Luiz Durigon

Human respiratory syncytial virus (HRSV) is the major cause of lower respiratory tract infections in children under 5 years of age and the elderly, causing annual disease outbreaks during the fall and winter. Multiple lineages of the HRSVA and HRSVB serotypes co-circulate within a single outbreak and display a strongly temporal pattern of genetic variation, with a replacement of dominant genotypes occurring during consecutive years. In the present study we utilized phylogenetic methods to detect and map sites subject to adaptive evolution in the G protein of HRSVA and HRSVB. A total of 29 and 23 amino acid sites were found to be putatively positively selected in HRSVA and HRSVB, respectively. Several of these sites defined genotypes and lineages within genotypes in both groups, and correlated well with epitopes previously described in group A. Remarkably, 18 of these positively selected tended to revert in time to a previous codon state, producing a “flip-flop” phylogenetic pattern. Such frequent evolutionary reversals in HRSV are indicative of a combination of frequent positive selection, reflecting the changing immune status of the human population, and a limited repertoire of functionally viable amino acids at specific amino acid sites.


Journal of Molecular Evolution | 2001

Evolution of base composition and codon usage bias in the genus Flavivirus.

Gareth M. Jenkins; Mark Pagel; Ernest A. Gould; Paolo Marinho de Andrade Zanotto; Edward C. Holmes

Abstract. The extent to which base composition and codon usage vary among RNA viruses, and the possible causes of this bias, is undetermined in most cases. A maximum-likelihood statistical method was used to test whether base composition and codon usage bias covary with arthropod association in the genus Flavivirus, a major source of disease in humans and animals. Flaviviruses are transmitted by mosquitoes, by ticks, or directly between vertebrate hosts. Those viruses associated with ticks were found to have a significantly lower G+C content than non-vector-borne flaviviruses and this difference was present throughout the genome at all amino acids and codon positions. In contrast, mosquito-borne viruses had an intermediate G+C content which was not significantly different from those of the other two groups. In addition, biases in dinucleotide and codon usage that were independent of base composition were detected in all flaviviruses, but these did not covary with arthropod association. However, the overall effect of these biases was slight, suggesting only weak selection at synonymous sites. A preliminary analysis of base composition, codon usage, and vector specificity in other RNA virus families also revealed a possible association between base composition and vector specificity, although with biases different from those seen in the Flavivirus genus.


Advances in Virus Research | 2001

Evolution, epidemiology, and dispersal of flaviviruses revealed by molecular phylogenies.

Ernest A. Gould; de Lamballerie X; Paolo Marinho de Andrade Zanotto; Edward C. Holmes

Publisher Summary This chapter reviews the current knowledge of flavivirus phylogeny and illustrates the significance of arthropods, habitats, and vertebrates, including humans, in their evolution, epidemiology, and dispersal. For a long time, it has been assumed that the opportunity for genetic variation among the arboviruses is significantly constrained by their need to replicate in both vertebrate and invertebrate hosts. In this sense, the flaviviruses present an interesting case for analysis, because the genus Flavivirus contains both arthropod-vectored and nonvectored viruses. The genus Flavivirus contains approximately 70 antigenically related viruses, many of which infect both vertebrate and invertebrate species. The flaviviruses that have no known vectors (NKV) are associated either with rodents or bats. The individual bat-associated NKV viruses are found either in the New World or in the Old World but none so far has been found in both regions. Despite the clear evidence that many of the flaviviruses are transmitted among vertebrate hosts by arthropods, it is known that they can also be transmitted orally and transplacentally.


Molecular Biology and Evolution | 2008

High Rates of Molecular Evolution in Hantaviruses

Cadhla Ramsden; Fernando Lucas de Melo; Luiz. M. Figueiredo; Edward C. Holmes; Paolo Marinho de Andrade Zanotto

Hantaviruses are rodent-borne Bunyaviruses that infect the Arvicolinae, Murinae, and Sigmodontinae subfamilies of Muridae. The rate of molecular evolution in the hantaviruses has been previously estimated at approximately 10(-7) nucleotide substitutions per site, per year (substitutions/site/year), based on the assumption of codivergence and hence shared divergence times with their rodent hosts. If substantiated, this would make the hantaviruses among the slowest evolving of all RNA viruses. However, as hantaviruses replicate with an RNA-dependent RNA polymerase, with error rates in the region of one mutation per genome replication, this low rate of nucleotide substitution is anomalous. Here, we use a Bayesian coalescent approach to estimate the rate of nucleotide substitution from serially sampled gene sequence data for hantaviruses known to infect each of the 3 rodent subfamilies: Araraquara virus (Sigmodontinae), Dobrava virus (Murinae), Puumala virus (Arvicolinae), and Tula virus (Arvicolinae). Our results reveal that hantaviruses exhibit short-term substitution rates of 10(-2) to 10(-4) substitutions/site/year and so are within the range exhibited by other RNA viruses. The disparity between this substitution rate and that estimated assuming rodent-hantavirus codivergence suggests that the codivergence hypothesis may need to be reevaluated.


Emerging Infectious Diseases | 2009

Hantavirus Pulmonary Syndrome, Central Plateau, Southeastern, and Southern Brazil

Luiz Tadeu Moraes Figueiredo; Marcos Lázaro Moreli; Ricardo Luiz Moro de Sousa; Alessandra Abel Borges; Glauciane Garcia de Figueiredo; Alex Martins Machado; Ivani Bisordi; Teresa Keico Nagasse-Sugahara; Akemi Suzuki; Luiz Eloy Pereira; Renato Pereira de Souza; Luiza Terezinha Madia de Souza; Carla Torres Braconi; Charlotte Marianna Hársi; Paolo Marinho de Andrade Zanotto

This syndrome is an increasing health problem because of human encroachment into habitats of rodent reservoirs.


Infection, Genetics and Evolution | 2009

Phylogeography and evolutionary history of dengue virus type 3

Josélio Maria Galvão de Araújo; Rita Maria Ribeiro Nogueira; Hermann G. Schatzmayr; Paolo Marinho de Andrade Zanotto; Gonzalo Bello

In this study, we revisited the phylogeography of the three of major DENV-3 genotypes and estimated its rate of evolution, based on the analysis of the envelope (E) gene of 200 strains isolated from 31 different countries around the world over a time period of 50 years (1956-2006). Our phylogenetic analysis revealed a geographical subdivision of DENV-3 population in several country-specific clades. Migration patterns of the main DENV-3 genotypes showed that genotype I was mainly circumspect to the maritime portion of Southeast-Asia and South Pacific, genotype II stayed within continental areas in South-East Asia, while genotype III spread across Asia, East Africa and into the Americas. No evidence for rampant co-circulation of distinct genotypes in a single locality was found, suggesting that some factors, other than geographic proximity, may limit the continual dispersion and reintroduction of new DENV-3 variants. Estimates of the evolutionary rate revealed no significant differences among major DENV-3 genotypes. The mean evolutionary rate of DENV-3 in areas with long-term endemic transmissions (i.e., Indonesia and Thailand) was similar to that observed in the Americas, which have been experiencing a more recent dengue spread. We estimated the origin of DENV-3 virus around 1890, and the emergence of current diversity of main DENV-3 genotypes between the middle 1960s and the middle 1970s, coinciding with human population growth, urbanization, and massive human movement, and with the description of the first cases of DENV-3 hemorrhagic fever in Asia.

Collaboration


Dive into the Paolo Marinho de Andrade Zanotto's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Atila Iamarino

University of São Paulo

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge